デフォルト表紙
市場調査レポート
商品コード
1481379

心臓弁の世界市場規模、シェア、成長分析、タイプ別、ポジション別、エンドユーザー別、治療別- 産業予測、2024年~2031年

Global Cardiac Valve Market Size, Share, Growth Analysis, By Types, By Position, By End User, By Treatment - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
心臓弁の世界市場規模、シェア、成長分析、タイプ別、ポジション別、エンドユーザー別、治療別- 産業予測、2024年~2031年
出版日: 2024年05月19日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

心臓弁の世界市場規模は2022年に72億米ドルと評価され、2023年の76億7,000万米ドルから2031年には126億9,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは6.50%で成長する見通しです。

技術の進歩は、心不全を含む心血管疾患の管理に革命をもたらし、治療アプローチを根本的に変えています。心疾患の有病率が上昇する中、この増大する健康課題に対処するための先端製品の開拓に明確な焦点が当てられています。このような技術革新の重視は、予測可能な将来において心血管疾患管理に大きな影響を与えると予想され、業界の大手企業は、市場成長をさらに促進し、治療手法を強化すると思われる新製品を発表しています。2023年から2030年にかけて予想される心臓弁市場の成長は、様々な要因、特に心血管疾患に罹患する世界人口の増加によって促進されるでしょう。心臓弁膜症から冠動脈疾患まで、心臓に関連する疾患の急増は、最適な心臓機能を回復させ、患者の予後を大幅に向上させる重要な介入である心臓弁置換術への需要の高まりにつながっています。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の危機と限界

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

心臓弁の世界市場:タイプ別

  • 市場概要
  • 機械弁
  • 組織弁/生体弁
  • 経カテーテル心臓弁/経皮心臓弁
  • その他

心臓弁の世界市場:ポジション別

  • 市場概要
  • 僧帽弁
  • 大動脈弁とその他の位置

心臓弁の世界市場:エンドユーザー別

  • 市場概要
  • 心臓研究
  • 病院・クリニック
  • 専門センター
  • その他

心臓弁の世界市場:治療別

  • 市場概要
  • 心臓壁の修復
  • および心臓壁置換術。

心臓弁の世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Medtronic
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • LivaNova PLC
  • Abbott
  • CryoLife Inc
  • On-X Life Technologies Inc.
  • Colibri Heart Valve
  • JenaValve Technology Inc.
  • TTK HealthCare
  • LivaNova PLC
  • Abbott Laboratories
  • Colibri Heart Valve LLC
  • Artivion Inc.
  • Lepu Medical Technology Co Ltd.
目次
Product Code: SQMIG35A2806

Global Cardiac Valve Market size was valued at USD 7.20 billion in 2022 and is poised to grow from USD 7.67 billion in 2023 to USD 12.69 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031).

Technological advancements are revolutionizing the management of cardiovascular diseases, including heart failure, fundamentally altering treatment approaches. With the prevalence of cardiac conditions on the rise, there's a clear focus on pioneering advanced products to address this growing health challenge. This emphasis on innovation is expected to significantly impact cardiovascular disease management in the foreseeable future, with major industry players introducing novel products that are likely to drive market growth further and enhance treatment methodologies. The anticipated growth in the cardiac valve market from 2023 to 2030 will be propelled by various factors, notably the increasing global population affected by cardiovascular diseases. This surge in heart-related ailments, ranging from valvular disorders to coronary artery disease, has led to a heightened demand for cardiac valve replacements, crucial interventions that restore optimal cardiac function and greatly enhance patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Valve Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Valve Market Segmental Analysis

The global Cardiac Valve market can be categorized into the following segments. Based on Types, the market can be categorized into Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves And Others. Based on Treatment, the market can be categorized into Cardiac Wall Repair, Cardiac Wall Replacement. Based on Position, the market can be categorized into Mitral Valve, Aortic Valve And Other Position. Based on Treatment, the market can be categorized into Cardiac Valve Replacement, Cardiac Valve Repair And Other. Based on End User, the market can be categorized into Cardiac Research Institute, Hospital & Clinics, Specialty Centers And Others. Based on Region, the market can be categorized into North America, Europe, Asia Pacific, The Middle East and Africa.

Drivers of the Global Cardiac Valve Market

The burgeoning elderly population, along with the trend towards more sedentary habits, is a key factor fueling the expansion of the market. Progress in heart valve technology and greater recognition of surgical options are additional contributors to this surge, particularly due to the rising demand for minimally invasive treatments. For example, according to the American College of Cardiology, around 5 million Americans grapple with heart valve disease each year..

Restraints in the Global Cardiac Valve Market

Significant hurdles impede the advancement of the market, primarily stemming from stringent government regulations dictating the progression, production, and application of medical products, particularly cardiac valves. Adhering to these regulatory frameworks entails a complex and resource-intensive process, involving extensive testing and meticulous documentation to ensure the safety and efficacy of these vital medical devices.

Market Trends of the Global Cardiac Valve Market

The expanding Cardiac Valve devices market is driven by several key factors, notably the rising prevalence of heart valve diseases and the approval of new and improved cardiac valves by regulatory bodies. This growth is particularly propelled by the increasing incidence of conditions such as rheumatic heart disease, which affects approximately 39 million people worldwide according to the World Heart Federation's 2022 report. Rheumatic heart disease, resulting from chronic rheumatic fever affecting heart valves, underscores the urgent demand for innovative solutions in cardiac valve technology.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Cardiac Valve Market by Types

  • Market Overview
  • Mechanical Valves
  • Tissue/Bioprosthetic Valves
  • Transcatheter Heart Valves/Percutaneous Heart Valves
  • and Others

Global Cardiac Valve Market by Position

  • Market Overview
  • Mitral Valve
  • Aortic Valve And Other Position

Global Cardiac Valve Market by End User

  • Market Overview
  • Cardiac Research Institute
  • Hospital & Clinics
  • Specialty Centers
  • And Others

Global Cardiac Valve Market by Treatment

  • Market Overview
  • Cardiac Wall Repair
  • and Cardiac Wall Replacement.

Global Cardiac Valve Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CryoLife Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • On-X Life Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colibri Heart Valve
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JenaValve Technology Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TTK HealthCare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Colibri Heart Valve LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artivion Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments